CanSino Biologics: MCV4 Obtains Argentine Registration Certificate

CanSino Biologics’ announcement: the company’s ACYW135 group meningococcal polysaccharide conjugate vaccine (CRM197 carrier) (MCV4, brand name: Manhyxin) has obtained the registration certificate granted by Argentina’s National Administration of Drugs, Food and Medical Devices.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned